VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Volitionrx Limited (VNRX) Tops Q3 EPS by 3c
November 10, 2016 8:13 AM ESTVolitionrx Limited (NYSE: VNRX) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).
Cash and cash equivalents as of September 30, 2016 totaled $12.5 million, compared with $14.5 million as of June 30, 2016 and $5.9 million as of December 31, 2015. As per previous press announcements, Volition raised an additional $12.4... More
